Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells

Published:2008-10-06 Issue:2 Volume:28 Page:209-218
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Baba T,Convery P A,Matsumura N,Whitaker R S,Kondoh E,Perry T,Huang Z,Bentley R C,Mori S,Fujii S,Marks J R,Berchuck A,Murphy S K

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2008374.pdf

Reference42 articles.

1. Balch C, Nephew KP, Huang TH, Bapat SA . (2007). Epigenetic ‘bivalently marked’ process of cancer stem cell-driven tumorigenesis. Bioessays 29: 842–845.

2. Bapat SA, Mali AM, Koppikar CB, Kurrey NK . (2005). Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res 65: 3025–3029.

3. Barrett T, Troup DB, Wilhite SE, Ledoux P, Rudnev D, Evangelista C et al. (2007). NCBI GEO: mining tens of millions of expression profiles—database and tools update. Nucleic Acids Res 35: D760–D765.

4. Beier D, Hau P, Proescholdt M, Lohmeier A, Wischhusen J, Oefner PJ et al. (2007). CD133(+) and CD133(−) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 67: 4010–4015.

5. Berchuck A, Iversen ES, Lancaster JM, Pittman J, Luo J, Lee P et al. (2005). Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers. Clin Cancer Res 11: 3686–3696.

Cited by 370 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of single cell sequencing technology in ovarian cancer research (review);Functional & Integrative Genomics;2024-08-28

2. Unveiling stem-like traits and chemoresistance mechanisms in ovarian cancer cells through the TGFβ1-PITX2A/B signaling axis;Biochemistry and Cell Biology;2024-07-08

3. Advances in ovarian tumor stem cells and therapy;Cell Biochemistry and Biophysics;2024-07-03

4. Exploring the Potential of Natural Killer Cell-Based Immunotherapy in Targeting High-Grade Serous Ovarian Carcinomas;Vaccines;2024-06-18

5. Global research landscape and trends of cancer stem cells from 1997 to 2023: A bibliometric analysis;Medicine;2024-05-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3